论文部分内容阅读
目的分析比较针对心力衰竭患者采用倍他乐克与依那普利治疗的临床效果。方法选取我院收治的心力衰竭患者66例,按照数字随机法随机分成倍他乐克组和依那普利组,倍他乐克组采取倍他乐克治疗,依那普利组采取依那普利治疗,比较两组治疗效果。结果两组患者治疗后左室收缩末期内径、左室射血分数、舒张晚期和早期流速峰值比均优于治疗前,差异有统计学意义(P<0.05)。依那普利组的总有效率93.94%,倍他乐克组的总有效率72.73%,依那普利组总有效率高于倍他乐克组,差异有统计学意义(P<0.05)。结论依那普利治疗心力衰竭效果优于倍他乐克,是一种心力衰竭的一线治疗药物。
Objective To analyze and compare the clinical effects of metoprolol and metoprolol in patients with heart failure. Methods Sixty-six patients with congestive heart failure admitted to our hospital were randomly divided into metoprolol group and enalapril group according to the digital randomization method, metoprolol group with metoprolol group, and metoprolol group with enalapril group NAP treatment, the treatment effect of two groups were compared. Results After treatment, left ventricular end-systolic diameter, left ventricular ejection fraction, late diastolic and early peak velocity were better in both groups than before treatment (P <0.05). The total effective rate was 93.94% in enalapril group and 72.73% in metoprolol group. The total effective rate in enalapril group was higher than that in metoprolol group (P <0.05) . Conclusions Enalapril is superior to Betaloc in the treatment of heart failure and is a first-line treatment for heart failure.